Dr. Joseph Fakhoury moderated a patient panel exploring the real-world experience of living with alopecia areata and treatment with Janus kinase (JAK) inhibitors. Panelists discussed their individual disease journeys, including early treatment experiences, the decision to transition to JAK inhibitor therapy, and factors that influenced their treatment choices. Dr. Fakhoury addressed common concerns about initiating treatment and was able to offer advice to patients preparing to discuss JAK inhibitors with their healthcare providers.
